AusBiotech’s bioeconomy building
20 October, 2008 by Kate McDonaldThe AusBiotech conference begins in Melbourne this Sunday. We talk to AusBiotech CEO Dr Anna Lavelle about building a bioeconomy.
Inside the head of the fishapod
16 October, 2008 by Kate McDonaldMore details of the internal head skeleton of Tiktaalik roseae revealed
Silent suppression for Antisense
15 October, 2008 by Dylan Bushell-EmblingATL1101 suppresses prostate tumour growth in animal models
CSL hopes for big profit
15 October, 2008 by Dylan Bushell-EmblingCSL predicts strong FY09 despite market crisis
Bonobos and the evolution of male aggression
15 October, 2008 by Kate McDonaldGerman researchers observe male and female bonobos hunting other primates
ChemGenex completes SPP
14 October, 2008 by Dylan Bushell-EmblingChemGenex raises $13m for late-stage R&D
ImClone licenses VEGFR antibody
14 October, 2008 by Dylan Bushell-EmblingImClone to develop Vegenics’ VEGFR-3 inhibitor as pre-clinical candidate
Big surprise for biotech from quarter one
08 October, 2008 by Dylan Bushell-EmblingLife sciences sector bounces back in Q1FY09, showing positive growth
No brainer for BrainZ
08 October, 2008 by Dylan Bushell-EmblingUS company Natus is after NZ’s BrainZ
More supply for AtCor
08 October, 2008 by Dylan Bushell-EmblingAtCor wins supply contract for SphygmoCor
No shock for USCOM
08 October, 2008 by Dylan Bushell-EmblingUSCOM improves paediatric septic shock management
Half-dose for Halcygen
07 October, 2008 by Dylan Bushell-EmblingHalcygen completes first required IND trial
PolyNovo trade agreed
02 October, 2008 by Dylan Bushell-EmblingXceed and Metabolic trade PolyNovo Biomaterials
